Research Projects

(PL) Opracowanie funkcjonalnego trójwymiarowego modelu tkankowego przerzutu nowotworu do kości z zastosowaniem metod inżynierii tkankowej

(EN) Development of Functional Three-Dimensional Bone Metastasis Model with Tissue Engineering Approach

Acronym: BonMetFun

Grant Number: UMO-2020/39/I/ST5/03473 – NCN (call: OPUS-LAP)

Implementation period: 02.11.21 – 01.11.2025

Description: The overall aim of this project is to develop a novel functional three-dimensional ex vivo Bone Metastasis Model, that will allow to investigate the mechanism of cancer (breast, prostate, lung) progression towards bone. By this, the project will focus on engineering of bone organoid consisting of vessel, bone marrow and bone. Therefore, it is proposed that the model recapitulating the structure and biological features of native vascularized bone tissue will be developed using an innovative method of bio fabrication – 3D bioprinting with the use of cell-instructive bio-inks. Multi-biomaterial and multi cell-type 3D printing will be employed to fabricate biomimetic and functional tissues. One important aspects of such engineered tissues for the study of cancer metastasis, is a functional, through vessel-mimicking channel, perfusion establishment. This, comparable to the in vivo situation will serve the nourishing of the tissue, but also will act as a medium for the shipment of circulating tumor cells. Additionally, the blood mononuclear cells, to mimic the blood environment will be incorporated into perfused engineered bone organoid, and as a result, their effect on cancer cells extravasation will be evaluated. Ultimately, the knowledge gained in the field of biomaterials, biofabrication and cell (cancer) biology will provide a stepping stone to establishment of personalized urgently needed platform (here bone metastasis model) for specific drug evaluation. 

Cooperation entities:

  • Faculty of Materials Science and Engineering, Warsaw University of Technology
  • University of Zurich, Switzerland 

(PL) Opracowanie trójwymiarowego biomimitycznego modelu inwazji komórek nowotworowych piersi w celu testowania nowych rozwiązań terapeutycznych

(EN) 3D biomimetic breast cancer invasion model for testing new therapies


Grant Number: POLTUR4/BIOCANCER/3/2021 – NCBR

Implementation period: 01.03.22 – 29.02.2024

Description: Survival prognosis for patients with advance breast cancer metastasis are rather poor and the available treatment options are also very limited. In currently available cell culture and laboratory animal-based cancer models, the underlying mechanism of breast cancer cells dissemination and its survival at distant locations is still not clearly identified. Despite unprecedented progress of research in tissue engineering and regenerative medicine, simple 3D tissue models that attempt to recapitulate cancer and capillary network, do not use its combination. At that point, there is a pressing need for development of an in vitro platform to investigate complex and pathophysiologically relevant research questions towards the understanding of breast cancer metastatic progression to the distant locations, namely its invasion and intravasation. Here, we propose a cancer intravasation-on-a-chip system allowing tracking of circulating breast cancer tumor cells within a fluidic device that is expected to respond to circulating immune cells. Therefore, the overall objective of this project is to establish a breast cancer intravasation model to test new therapeutic strategies. To reach the project principal, specific, project-related activities will be integrated into four aims:

  1. To develop 3D breast cancer model, which will be obligatory for intravasation testing in presence of perfused vascular lumen in Aim 3 and Aim 4;
  2. To establish perfused engineered blood vessel, which will recapitulate biological hollow like structure to study invasion of breast cancer cells in Aim 3 and Aim 4;
  3. To developed perfused vascularized 3D multi-tissue construct by combining Aim 1 and Aim 2;
  4. To investigate the role of immune cells on breast cancer cell intravasation using developed 3D vascularized cancer model (Aim 3).

The main result of the project, which applies to development of novel breast cancer intravasation model will be of high interest for biomaterials and biomedical companies as for the pharmaceutical industry. It is expected that it will also help in understanding the breast cancer cells interactions with constant changing environment during dissemination and metastasis formation. Furthermore, it could be also used in personalized medicine by selection the most effective treatment for individual patients using patient’s own cells in the 3D model.

Cooperation entities:

  • Faculty of Materials Science and Engineering, Warsaw University of Technology
  • Ege University, Izmir (Turkey)

(PL) Opracowanie konstrukcji i technologii wytwarzania nowatorskich bioaktywnych implantów stomatologicznych

(EN) Development of construction and technology for the production of innovative bioactive dental implants


Grant: MAZOWSZE/0023/19

Implementation period: 02.03.2020 – 28.02.2023

Description: The project aims to develop the structure and to produce by incremental 3D printing SLM (Selective Laser Melting) a series of intraosseous dental implants distinguished from the competition by the possibility of applying biologically active agents directly to the surrounding soft tissues and bone tissue and their substitutes to improve the treatment process. As part of the project, 3D printing parameters will be developed by the method of selective laser melting of technically pure titanium (Ti-CP) and Ti-6Al-4V (Ti Grade 5) alloy for dental implants with a modified architecture (internal structure) by using open porosity and specially designed internal channels. Open porosity introduced into the design of implants will enable the reduction of Young’s modulus to a value lower than in commercially used solid implants and improve osteoconductivity, and the system of innovative internal channels will enable the delivery of biologically active agents to the diseased tissue, which is not currently available on the market.

Cooperation entities:

  • Wychowanski Stomatologia Sp. z o. o. – Leader
  • Faculty of Materials Science and Engineering, Warsaw University of Technology
  • MaterialsCare Sp. z o. o

(PL) Synteza i charakterystyka nowych biomateriałów na bazie trójwymiarowych (3D) wielofunkcyjnych podłoży tytanowych

(EN) Synthesis and characterisation of novel biomaterials based on three-dimensional (3D) multifunctional titanium substrates

Grant: OPUS.13 2017/25/B/ST8/01599 – NCN

Implementation period: 2018 – 2021

Description: The increased number of cases of osteoporosis, has resulted in a significant increase in the number of bone implant procedures performed recently. The research hypothesis of the proposed project assumes that by combining computer modelling, 3D printing and the process of anodic oxidation of metals, it will be possible to synthesize a new three-dimensional titanium-based biomaterial that will have a structure with complex porosity, both on the micro- and nano-scale, and exhibit the desired mechanical properties.

Cooperation entities:

  • Jagiellonian University – Krakow, Poland
  • Faculty of Materials Science and Engineering, Warsaw University of Technology

(PL) Cyfrowe wytwarzanie funkcjonalnych materiałów gradientowych wspomagane metodami sztucznej inteligencji: krok w kierunku materiałów porowatych nowej generacji

(EN) Artificial intelligence-assisted 3D digital manufacturing of functionally graded materials: towards the next generation of porous materials

Grant: OPUS 505/00964/1090/46.000011 – NCN

Implementation period: 2021 – 2024

Description: The goal of this project is the development of new tools for the design and manufacturing of 3D porous functionally graded materials (pFGMs) that exhibit tailored mechanical properties, in particular pre-designed energy absorption profiles. It is proposed a new approach toward the design and fabrication of pFGM aimed at i) developing efficient in silico (numerical) modelling of such complex materials enabling the design of porous structures with required mechanical properties, and ii) simplifying/extending the manufacturing procedures.

Cooperation entities:

  • Institute of Physical Chemistry, Polish Academy of Sciences – Warsaw, Poland
  • Faculty of Materials Science and Engineering, Warsaw University of Technology

(PL) Nowe funkcjonalne MATeriały do druku 3D w zakresie potrzeb UROlogicznych

(EN) New functional MATerials for 3D printing in UROlogy needs

Acronym: MATURO 3D

Grant: TECHMATSTRATEG2/407770/2/NCBR/2020

Implementation period: 01.05.2020 – 30.04.2023

Description: The main objective of the project is to develop materials from which it will be possible to produce a biodegradable substitute for urethra reconstruction of urethral defects in children and adults. The Biomaterials group (Faculty of Materials Science and Engineering, Warsaw University of Technology) is responsible for the development of the biomaterials, as well as for the design and fabrication of the prototype of the inner layer of the artificial urethra.

Cooperation entities:

  • Politechnika Łódzka, Wydział Mechaniczny (Lider)
  • Politechnika Warszawska; Wydział Inżynierii Materiałowej
  • Uniwersytet Mikołaja Kopernika; Wydział Chemii
  • Wolf Project Studio / Sygnis

(PL) Osteoindukcyjne hydrożele do regeneracji tkanki kostnej i biodrukowania

(EN) Osteoinductive hydrogels for regeneration of bone tissue and bioprinting

Grant: Centrum Badawcze POB – Technologie Materiałowe – 1

Implementation period: 01.07.2020 – 30.06.2022

Description: The goal of this project is to develop a bioink containing solubilized dECM isolated from porcine bone. To this end, we will develop demineralization and decellularization protocols for the porcine bone tissue. The resulting bdECM will be dissolved employing pepsin digestion and characterised in terms of its biochemical composition. The bioinks will be characterized through rheology and gelation kinetics. The printability of bdECM hydrogels will be examined by employing 3D-printer. BdECM bioinks will be also tested for their cytocompatibility using human mesenchymal stem cells. The ability of hydrogels to support cell proliferation and induce osteogenic differentiation will be assessed using biochemical tests, staining and microcomputed tomography. Finally, the osteoinductive potential of the bdECM hydrogels will be evaluated in vivo in a rat model.

Cooperation entities:

  • Faculty of Materials Science and Engineering, Warsaw University of Technology

(PL) Promowanie bezpieczeństwa pacjentów przez złez złozóne nowocyesne badania obrazowania implantów z biodegradowalnego magnezu

(EN) Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants

Acronym: MgSafe

Grant: 811226 Horizon Programme Marie Sklodowska-Curie Innovative Training Networks (H2020-MSCA-ITN)

Implementation period: 01.10.2018 – 30.09.2022

Description: Biomedical imaging has received a substantial technological advance and has become the standard for diagnosis and therapy monitoring. Still, imaging for the new class of biodegradable Mg-based implants is not yet optimal. MgSafe will address this issue by educating 15 ESRs in imaging and implant technology. ESRs will quantify the physical impact and appropriateness of multiple modalities on Mg implants. Two Mg-alloys and Mg-implants certified by the CE will be examined in rats and lambs. At WUT, the ex vivo surface characterization of implants before implantation and surface and cross-section analysis of explants by High-resolution imaging technique will be performed as well as the surface topography and chemical composition will be investigated.

Cooperation entities:

  • Helmholtz-Zentrum Hereon – Centre for Materials and Coastal Research GmbH (Germany)
  • Consiglio Nazionale Delle Ricerche (CNR-IFC, Italy)
  • Medical University of Graz (MUG, Austria)
  • University of Oslo (UiO, Norway)
  • OsloMet-University (OsloMet, Norway)
  • Hannover Medical School (MHH, Germany)
  • University of Gothenburg (UGOT, Sweden)
  • MRI.Tools GmbH (Germany)
  • Syntellix AG (SYN, Germany)
  • Scanco Medical AG (Switzerland)
  • FUJIFILM sonosite BV (VSI, The Netherlands)
  • Warsaw University of Technology, Faculty of Material Science and Engineering, Warsaw (Poland)

(PL) Rozwój zaawansowanych stopów magnezu przeznaczonych do pracy w warunkach ekstremalnych

(EN) Development of Advanced Magnesium Alloys for Multifunctional Applications in Extreme Environments

Acronym: MagMAX

Grant: V4-JAPAN/2/15/MagMAX/2022, Visegrad Group (V4) – Japan Joint Research Program of Advanced Materials

Implementation period: 1.09.2022 – 31.01.2025

Description: This project’s primary objective is to provide a transition-driven, science-based methodology for the creation of the next generation of magnesium alloys, containing the LPSO phase, that enables their use in extreme environments. These will accomplish by application opportunity and property requirement analysis, computational materials science and data science calculations, controllable microstructure-property relationship fine-tuning, biocompatible medical device characterization, corrosion science and surface protection, and exhaustive testing for structural and biomedical applications in extreme environments which comprise the primary research methodology. At WUT, the behaviour of as-prepared and coated Mg-LPSO alloys for engineering applications in corrosion environments as well as the corrosion performance of these alloys for biomedical applications will be investigated.

Cooperation entities:

  • Charles University, Faculty of Mathematics and Physics (Czech Republic)
  • Kumamoto University, Magnesium Research Center (Japan)
  • Eötvös Loránd University, Institute of Physics (Hungary)
  • Slovak Academy of Sciences, Institute of Material Research, (Slovakia)
  • Warsaw University of Technology, Faculty of Material Science and Engineering, Warsaw (Poland) 

(PL) Opracowanie technologii nieniszczącego diagnozowania gazociągów w oparciu o magnetyczną metodę bezkontaktową i sensory zintegrowane z wykorzystaniem algorytmów uczenia maszynowego

(EN) Development of non-destructive diagnosis of gas pipelines based on non-contact magnetic method and sensors integrated with the use of machine learning algorithms

Acronym: TNDG

Grant: POIR.04.01.01-00-0052/18

Implementation period: 1.05.2019 – 30.10.2022

Description: The project aims to carry out R&D works as a result of which will be developed a technology for non-destructive diagnosis of gas pipelines based on non-contact magnetic methods and sensors integrated with the use of machine learning algorithms. The employees of the Consortium Leader together with the Consortium Partner based on their experience and ongoing work in the field of technical diagnostics with non-destructive methods (NDT) and material research developed conceptual assumptions regarding the innovative service of non-destructive diagnosis of gas pipelines.

Cooperation entities:

  • Warsaw University of Technology, Faculty of Materials Science and Engineering, Warsaw (Poland)
  • Energodiagnostyka Sp. z o.o.

(PL) Opracowanie technologii wytwarzania nowej generacji implantów tytanowych do stabilizacji złamań kostnych, o zwiększonej biozgodności uzyskiwanej dzięki eliminacji cytotoksycznych dodatków stopowych

(EN) Technology development for manufacturing a new generation of titanium implants for stabilization of fractured bones with increased biocompatibility achieved by the elimination of cytotoxic alloys


Grant: LIDER 0078/L-11/2019

Implementation period: 1.01.2021 – 31.12.2023

Description: The project consists in developing a modern technology for the production of a new generation of titanium implants for stabilizing bone fractures. The key element of the project is the production of biocompatible composite tiles and intramedullary nails made of pure titanium (Ti-CP) used for bone reconstruction, by using a unique and innovative method of explosive deformation. Thanks to the applied technology, the developed medical devices will be characterised by unique biocompatibility, lack of alloy additives, high mechanical strength, and lower weight. The use of titanium (Ti-CP), in which the strength properties will be obtained without the use of alloying elements, will reduce the cost of material by eliminating the need for expensive, deficient and cytotoxic elements such as aluminium, niobium, tantalum or zirconium. Moreover, it will significantly increase the utility by enhancing biocompatibility. The increased strength obtained by the explosion deformation will reduce the diameter of the bolts, and thus reduce the diameter of the holes drilled in the bone, necessary for fixation of the nail. This will reduce bone destruction and increase its stability and regeneration rate in the case of temporary implants.

Cooperation entities:

  • Warsaw University of Technology
  • UCB Pharma Sp. z o.o.

(PL) Zaawansowane biokompozyty dla gospodarki jutra

(EN) Advanced biocomposites for tomorrow

Acronym: BIO-GNET

Grant: Operational Program 2014-2020 (OP IE), Axis IV: Increasing the research potential, Action 4.4: Increasing the human potential in the R&D sector, TEAM-NET program.

Implementation period: 1.10.2019 – 30.06.2023

Description: The main subject of the project research concern the use of microorganisms to search for innovative solutions in modern technologies, especially in the design and manufacture of new, mixed nanocomposite, porous materials (metal-protein type). The overall objective of this project is biosynthesis and characterization of new materials properties based on zinc and silver oxide nanoparticles and biosilica doped with transition metal ions. In the next stage of the research methods that allow their physicochemical characteristics and, consequently, their application in medical devices, cosmetics, household chemistry and the food industry will also be used.

Cooperation entities:

  • Politechnika Warszawska
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet warmińsko-mazurski w Olsztynie
  • Politechnika Białostocka
  • Uniwersytet Szczeciński 

(PL) Lodofobowe powierzchnie dla komponentów na bazie kompozytów polimerowych

(EN) ICEphobic SURfaces for components based on polymER composites

Acronym: ICE Surfer

Grant: LIDER/16/0068/L-9/17/NCBR/2018

Implementation period: 01.01.2019 – 30.12.2022

Description: IceSurfer project will offer laser surface texturing of modified polyester and epoxide-based gelcoats and epoxy paints utilized for surface protection of fibres reinforced polymer composites. An attractive approach to this issue is the development of icephobic laser-treated surfaces for composite components which reduce or prevent ice accretion. For this purpose, two kinds of laser devices will be used. Additionally texturing will be preceded by bulk chemical and nano/micro additives modifications of polymers. It is expected to develop durable and effective surfaces with icephobic features that can sufficiently reduce water and ice adhesion as well as slow down ice nucleation, so that supercooled water droplets landing on the surface can be removed effectively before freezing. Thus, proposed developments will constitute a good alternative for presently used in practice electro thermal active systems. Taking into consideration future applications in industrial environments all methods will meet demands regarding the economy, environmentally friendly practices and be feasible to use on a large industrial scale.

Cooperation entities:

  • Warsaw University of Technology 

(PL) EUROfusion – Realizacja działań opisanych w Mapie Drogowej dla Fuzji Jądrowej w ramach programu Horyzont Europa poprzez wspólny program członków konsorcjum EUROfusion

(EN) Implementaton of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium


Grant: PR UE Horyzont Europa EURATOM

Implementation period: 1.01.2021 – 31.12.2025

Description: The project aims to develop energy based on a controlled thermonuclear fusion. As part of the project: hot plasma research is carried out in existing experimental fusion reactors; another experimental ITER reactor is being built in Cadarache (France), which is to be a decisive step towards demonstrating the possibility of generating electricity from nuclear fusion, and design work is underway on the world’s first prototype fusion power plant DEMO with a capacity of several hundred MWs.

Cooperation entities:

  • Over 30 research institutes/universities across Europe.

(EN) Advanced biomaterial and biofabrication methods for engineering the myotendinous junction

Acronym: BioMotion 

Grant: PLTW/VI/3/2019

Implementation period: 1.02.2019 – 31.05.2023

Description: In the Biomotion project a novel microfluidic-based approach has been used for the 3D biofabrication of the myotendinous junction. Specifically, multiple naturally derived biomaterials and multiple cell types (skeletal muscle and tendon progenitors) have been employed for engineering the complex heterogeneous structure.

Cooperation entities:

  • Warsaw University of Technology, Faculty of Materials Science and Engineering, Warsaw (Poland)
  • National Taiwan University, Institute of Biomedical Engineering, Taipei (Taiwan)

(PL) Kontrastujące cząstki HAP-ICG i ich wpływ na mikrostrukturę oraz właściwości kompozytu PCL-HAP-ICG do bimodalnego obrazowania medycznego z wykorzystaniem promieniowania rentgenowskiego i fluorescencji w bliskiej podczerwieni

(EN) HAP-ICG contrasting particles and their impact on microstructure and properties of PCL-HAP-ICG composite for bimodal medical imaging using X-rays and fluorescence in near-infrared

Grant: 2020/37/N/ST5/04137

Implementation period: 22.01.2021 – 21.01.2024

Description: The project aims to develop HAP-ICG particles with contrasting properties for bimodal imaging using X-rays and Near-Infrared fluorescence and to investigate how newly developed HAP-ICG particles will influence the microstructure and properties of PCL-HAP-ICG composite. The proposed systematic study will allow us to establish key factors affecting cell response and stability of contrasting and mechanical properties of PCL-HAP-ICG composite. Moreover, the planned multi-technique study of developed HAP-ICG particles and PCL-HAP-ICG composite will provide new information about materials for bimodal medical imaging.

Cooperation entities:

  • Warsaw University of Technology, Faculty of Materials Science and Engineering, Warsaw (Poland) 

(PL) Wykorzystanie metod inżynierii biomateriałów do opracowania modelu tkankowego zdrowej i zmienionej nowotworowo kości w celu badania inwazji komórek kostniakomięsaka

(EN) Development of biomaterial-assisted tissue-engineered healthy and malignant bone tissue model to study osteosarcoma cell invasion

Grant: UMO-2021/41/N/ST5/04220 – NCN (type of call: Preludium20)

Implementation period: 20.01.22 – 19.01.2025

Description: This project aims to develop a novel biomaterial-assisted tissue-engineered in vitro model consisting of malignant and healthy bone tissue to investigate the invasion of cancer cells under mechanical stimuli. Thus, to reach the primary goal, the project will be divided into three aims:

Aim 1) To develop and optimize a bone tumour model consisting of 3D osteosarcoma spheroids (SaOS-2), generated by liquid overlay technique and embedded into hydrogel construct. By this, we aim to recreate distinct zones of tumour spheroid encountered in vivo. Simultaneously, Aim 1) gelatin methacrylol with varying stiffness will be used to recapitulate the malignant extracellular matrix by introducing adhesive sites to impose biomaterial-assisted cancer cell invasion in Aim 3; Aim 2) a healthy cancellous bone tissue model, fabricated from tricalcium-phosphate-loaded composites of poly(L-lactide-co-glycolide) and poly(L-lactide-co-ε-caprolactone) will be established. Precise extrusion deposition will be utilized for scaffolds’ fabrication, designed to allow bone tumour insertion (developed in Aim 1). Additionally, the engineered scaffolds will also be subjected to cyclic mechanical loading to recapitulate strong anabolic signal in the skeleton from mechanical stimuli. After that, the optimized conditions will be used for Aim 3. Cell seeding optimization (normal human osteoblasts and human umbilical vein endothelial cells) and biological evaluation (i.e., cell viability, ALP activity, expression of endothelial cell marker) will also be performed. Additionally, a polymerase chain reaction (PCR) will be conducted to detect the early features of osteogenesis.

Aim 3) To establish a hybrid 3D model for invasion testing. At this stage, a model of malignant bone tissue will be inserted into the healthy bone tissue model. The optimized and the best conditions developed in Aim 1 and 2 will be implemented at this stage. The invasion of cancer cells under static and dynamic conditions will be assessed by fluorescence microscopy. 

Cooperation entities:

  • Warsaw University of Technology, Faculty of Materials Science and Engineering, Warsaw (Poland)

(PL) Projektowanie i wytwarzanie wielowarstwowych bioaktywnych opatrunków do leczenia perforacji rogówki spowodowanej infekcją rogówki

(EN) Design and fabrication of the multilayer patches for the treatment of corneal perforations secondary to corneal infections

Acronym: CorPatch

Grant: POLTUR4/CorPatch/1/2021 – NCBiR – Polish-Turkish/Turkish-Polish 4th Call for Proposals

Implementation period: 01.02.2021 – 31.01.2024

Description: Microbial keratitis is a devastating vision-threatening ocular disease requiring immediate broadspectrumantimicrobial treatment to prevent scarring, corneal perforation and/or endophthalmitis.Therapy for the perforation disorders and degeneration processes has seen limited progress becauseof its degenerative nature and unrelenting course. The healing of a disrupted cornea is extremely protracted, due to limited regeneration capacity. Also, one of the greatest challenges in the treatment of secondary perforation is to overcome microbial infections and to obtain the optimal condition for keratoplasty. Conventional approaches based on mechanical removal of infected tissuedo not guarantee the infection is over, also scaring may occur, resulting with secondary infection andndegeneration of permanent donor cornea graft. Therefore, it becomes necessary to develop a new treatment strategies based on bioactive dressings enriched with drugs and inhibitors. Based on the previous experience of the Partners, literature studies and the preliminary result, the methodology has been defined to achieve the main goal of the project, which is the development of a novel hybrid multilayer corneal temporary patch (synthetic origin), that would allow for localized and controlled delivery of biological factors (drugs and quorum inhibitors) to the cornea perforation site.

Cooperation entities:

  • Warsaw University of Technology, Faculty of Materials Science and Engineering, Warsaw (Poland)
  • Marmara University (Turkey)

(PL) Opracowanie kompozycji metaliczno-polimerowych oraz technologii wytwarzania na ich bazie włóknin warstwowych o właściwościach przeciwdrobnoustrojowych i filtracyjnych dla produktów sanitarnych oraz ochrony medycznej

(EN) The development of antimicrobial and filtration layered fabrics for sanitary and medical protection and fabrication technology based on metal-polymer composites

Acronym: Włókniny

Grant: POIR.01.01.01-00-1246/20 – Szybka ścieżka 5/1.1.1/2020

Implementation period: 10.10.2020 – 03.06.2023

Description: The project aims to develop technology for the multilayered nonwoven fabric production with the external layer showing antiseptic properties. This layer contains particles in the polymer matrix fiber that combines antispetic properties of silver and copper ions, cytostatic properties of ZnO and catalytic ones of TiO2. Additionally, the effective interaction of Ag+ and Cu2+ ions with microbes is possible in aqueous environment provided by hydrophilic Surface, containing ZnO and TiO2 particles, strenghtened by plasma or corona discharge in water containing atmosphere. The external composite layer of nonwoven fabrics will be deposited on hydrophobic supporting layer. The electrospinning, melt-blown and spunbond production techniques will be used for fabrication of the fabrics’ layers depending on their functions. The melt-blown method allowing for hydrophobic filtration fabrics production will be applied for the supporting layer fabrication. The internal fabrics layer will be made with the use of spunbond technology. Several options of the nonwoven fabrics are planned for different purposes. An important part of the research will be development of reliable biological tests for antiseptic properties of the nonwoven fabrics. The production technology of variable multilayered nonwoven fabrics showing virucidal, germicidal and fungicidal properties will be the project result. The nonwoven fabrics will be utilized for personal protective equipment, antispetic HEPA filters of different classes for application in air conditioning systems and in construction fleece fabrics.

Cooperation entities:

  • Warsaw University of Technology, Faculty of Materials Science and Engineering, Warsaw (Poland)
  • HPT Innovation Sp. z o.o.
  • CENTERA – Center for Terahertz Research and Applications

(PL) Nowa metoda regeneracji krążka międzykręgowego

(EN) A new regeneration method of intervertebral disc


Grant: POIR.04.01.04-00-0007/17-00

Implementation period: 01.02.2020 – 31.01.2023

Description: The main goal of the project is to develop a commercialization-ready working prototype of the Disc Repair System, dedicated to the treatment of intervertebral disc injuries. The components of the system are: a bioactive fibrous dressing for stabilization and regeneration of the annulus fibrousus, a dressing attachment mechanism, polymer capsules that restore the biofunctional parameters of the nucleus pulposus, and surgical instrumentation. The dressing will be a fiber mesh of biocomposite fibers (bioabsorbable/non-absorbable material) attached to the bone of adjacent vertebral bodies. Injectable swollen polymer capsules for restoring functions of the nucleus pulposus will be made of natural polymers (alginate, chitose, collagen) or synthetic ones, eg copolymers of acrylic acid and acrylamide or poloxamers. Treatment will also include an intra-disc transfer of intervertebral disc suspension containing autologous mesenchymal stem cells and cell nourishing structures (eg polymer nanofibres secreting cell growth factors). All dressing components and polymer capsules will comply with ISO 10993-5 and ISO 10993-12 standards.

 Cooperation entities:

  • Warsaw University of Technology, Faculty of Materials Science and Engineering, Warsaw (Poland)
  • Centre for Advanced Materials and Technologies (CEZAMAT), Warsaw (Poland)
  • GP Bionics Sp. z o.o.

Text Below – Last Update: 2019 


Method of treatment of large bone defects in oncological patients using in vivo tissue engineering approach

Acronym: iTE

Number: STRATEGMED3/306888/3/NCBR/2017


Finance Unit: NCBR (National Centre for Research and Development)

Project manager: dr hab. inż. Wojciech Święszkowski, prof. PW

Function: Project Leader

Term: 2017 – 2020

Project description:
The main goal of the project is to develop a novel scaffold-based in vivo tissue engineering approach to regenerate large bone defects (iTE) in oncological patients. In the first stage, after removal of the bone tumor, a novel drug delivery spacer will be implanted to mandible to restore defect site, and, in the same time, to cure possible infection and support radiotherapy and/or chemotherapy. In the same time a novel bioactive and biodegradable 3D scaffold will be implanted within ectopic site of patient body capable of supporting neo-tissue formation. After a new bone tissue will be generated in vivo, the spacer will be removed, and the prefabricated flap (tissue engineering product) will be harvested and implanted in mandibular defect offering both physiological performance and aesthetic improvements. To achieve that, a novel 3D printed spacer, bioactive scaffold, and method of enrichment implants with bioactive agents, will be proposed and evaluated based on extensive in vitro and in vivo (small and large animal models) investigations.

3D bioprinting of living pancreatic islets or insulin-produced cells into scaffolds of bionic pancreas

Acronym: BIONIC

Number: STRATEGMED3/305813/2/NCBR/2017


Finance Unit: NCBR (National Centre for Research and Development)

Project manager: Foundation of Research and Science Development

Term: 2017 – 2019

Project description:

In Poland, there are more than 2,5 millions diabetic patients, 200,000 of which are with type I. According to WHO’s, by 2030 these numbers will double. Islets transplantation is of a limited use because of ischemic injury. The isolation process, by stripping the islets of their vasculature and surrounding extracellular matrix (ECM) results in that, than 50% of transplanted islets are lost during the first few days. Bioprinting is extremely promising. Medical community, have already transplanted trachea and bladder 3Dbioprinted. There are a few weak points to be solved to achieve a 3Dprinted scaffold with islets. Bioengineered hydrogels allow to print islets and to keep them alive but function of those is limited. Another problem is the lack of vasculature. The main aim of the study is to 3D-bioprint a functional bionic pancreas consisted of proper ECM for islets, vasculature and islets or even further–insulin producing cells retrieved from the recipient. Results of our work might be helpful in planning to produce a completely new product – Human Bionic Pancreas.

Bioengineered in vitro model of retinal pigmented epithelium
of human eye



EU flag






Number: 2016/23/Z/ST8/04375

Program: UNISONO

Finance Unit: NCN (National Science Center)

Project managers: dr hab. inż. Wojciech Święszkowski, prof. PW

Function: Consortium Member 

Term: 2017 – 2020

One of the greatest challenges of European research on macular degeneration starts from Pisa. The “E. Piaggio” Research Centre at the University of Pisa is the coordinator of the BIOMEMBRANE research project, which aims to produce a “bionic eye” (using micro and nanofabricated bioactive materials) to test the efficacy of drugs and develop personalized therapies for maculopathy.

The project has recently received about 500,000 euro in funding in the context of Mera.Net, the EU funded network designed to support and increase the coordination of European research programs and related funding in the field of materials science and engineering, in which Poland is actively involved through the The National Science Centre (NCN). Prof. Wojciech Święszkowski is the Polish coordinator of the project.

“In the three years of the project we will create intelligent biostructures integrated into a biomedical platform able to mimic the structures of the eye to optimize pharmaceutical tests and personalize the therapies for macular degeneration”, explained Giovanni Vozzi, University of Pisa. “The device will have a major impact on healthcare costs as new materials and related in vitro models will be less costly than the ones currently in use”, concluded Vozzi.

The project involves the Warsaw University of Technology (Poland), the University of Pisa (Italy), the New University of Lisbon (Portugal), and the companies SNC Fibers (South Africa) and Allinky Biopharma (Spain).

Project description:

Age-Related Macular Degeneration (AMD) is the leading cause of blindness in the elderly worldwide: although it does not cause total blindness, there is a progressive loss of high-acuity vision attributable to degenerative and neovascular changes in the macula. Currently, there is neither a cure nor a means to prevent AMD. New discoveries, however, are beginning to provide a much clearer picture of the relevant cellular events and biochemical processes associated with early AMD and the ageing process in general. Although we do have a basic understanding of some of the processes involved in extra-cellular ageing, what comes first and what triggers what is still unclear. Four key phenomena are known to contribute to extracellular senescence: matrix stiffening due to cross-linking and fibrosis, a shift in the reactive oxygen species (ROS) generation/scavenging balance, neovascularization and inflammation. The main objective of BIOMEMBRANE project is the design and fabrication of an alternative and smart in vitro model to boost the discovery of new therapeutic strategies for age-related macular degeneration. The development of an in vitro model of retinal pigmented epithelium (RPE) interfaced to choroidal vascular network (CVN) is expected to provide a more reliable device for the pharmaceutical testing and the evaluation of custom therapies for each patient. This device, developed during the project, will have an important impact on health care costs as the new materials and the related in vitro models are expected to be more economic than the current testing system. To reach the goal, BIOMEMBRANE project will make use of innovative micro- and nano-fabrication system with bioactive materials to mimic the physiological role played by the Bruch’s membrane (BrM), the interface between CVN and RPE. Not only efficacy, standardisation and biocompatibility will be considered, but also the fidelity to reproduce the interface between RPE and the underlying vascular network, as most oxygen and nutrient supply to the outer retina is provided by the choroid. To mimic the topology of this eye structure two different micro and nanofabrication techniques will be combined. The BrM will be assembled using an electrospinning system able to produce an unwoven structure made of fibre with nanometers resolution and with a well-defined porosity at micro and nano level: this structure will be able to mimic the extracellular matrix (ECM) topology, which in turn affects the permeability of this cell-free barrier. The CVN will be designed as a branched microfluidic network, which will be fabricated using a soft lithographic approach. The bioactivity of the bioengineered structures will be improved with SOFT-MI method, by imprinting bioactive sites able to bond selectively selected biomolecules for enhancing cell functions. The cellularized bioengineered RPE and CVN substitutes will be integrated in a unique milli-structure, of the same size of a classic well for cell culture and connected to a peristaltic pump, to be the first biomimetic and dynamic in vitro model of this barrier. The concept of smart multiscale biostructures integrated in a bioengineered platform able to mimic eye’s structures, such as that we will create in BIOMEMBRANE project, will render the European biomaterials, pharmaceutical and biotechnological industries more productive and dynamic. At present these industries are struggling with regulatory issues, due to the fact that their products must comply with stringent pre-clinical testing requirements. Here we propose a novel biotechnological platform aimed at reducing experimental time and costs by mimicking a physiopathological environment difficult to analyse in vivo and develop custom in vitro tests for drug therapy efficacy.

Multidisciplinary European training network for development
of personalized anti-infective medical devices combining printing technologies and antimicrobial unctionality

Acronym: PRINT-AID

Number: H2020-MSCA-ITN-2016

Program: European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 722467

Finance Unit: Horizon 2020

Project manager: dr Karita Peltonen, University of Helsinki

Function: Consortium Member 

Term: 2016-2020

Project description:

The mission of PRINT-AID is to provide multi-disciplinary training in microbial biofilms, 3D-printing technologies and in vivo infection models. PRINT-AID consortium will offer a training programme for early-stage researchers to exploit the power of emerging technologies in order to explore innovative routes to counteract biofilm caused infections in medical devices. Our aim is to proof the value of developing a new generation of safer 3D-printed personalised medical devices with antimicrobial functionalities. We are going to use investigational drugs which inhibit bacterial colonisation or kill bacteria. These compounds will be incorporated in the medical device structure itself during the 3D printing process and they are expected to be released from there during a long period of time. By using 3D-printing, we can also customise the devices to fit the needs of the patients. The chances of this project to provide a safer alternative for pharma devices are really significant. In the project, state-of-the-art printing technologies will be combined with new in vitro and in vivo biofilm models as well as new tools for data integration and standardisation. The project brings together the leaders of their own areas in the personalised medicine and medical devices sector. The students have an opportunity to work both in the collaborating companies and in academia.The project also offers great opportunities for young researchers to move from academy into industry and vice versa, and get exposed to both environments.

Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants

Acronym: MgSafe

Number: MgSafe H2020-MSCA-ITN-2018 Grant agreement ID: 811226

Program: Marie Skłodowska-Curie Innovative Training Networks (ITN-ETN)

Finance Unit: Horizon 2020

Project manager: dr hab. inż. Wojciech Święszkowski, prof. PW

Function: Consortium Member 

Term: 2018-2022

Project description:

MgSafe is a European Training Network within the framework of Horizon 2020 Marie Skłodowska-Curie Action (MSCA) 2018. Within this action, 15 Early Stage Researchers (ESRs) address the optimisation of imaging technologies for biodegradable magnesium implants. Fractures are typically treated with non‐degradable metal implants, which commonly require surgical removal after complete bone healing. From the health care and patients’ point of view, degradable implants provide a viable, cost effective and patient friendly alternative. In 2013, the first degradable metal implant made from a Mg‐alloy (compression screw of partner SYNTELLIX) was CE certified and has be implanted into several 100 patients so far. Monitoring implant performance and degradation with the existing imaging techniques is a challenge. The ESRs of MgSafe will push the imaging modalities towards their limits to monitor the degradation processes of emerging Mg implants optimally and non‐invasively in animal models with high spatial and temporal resolution. The results of MgSafe will substantially increase the level of safety for patients currently treated with Mg‐based implants and will boost the further development of imaging modalities also on a clinical level. MgSafe will educate a new generation of young researchers needed for the development of high‐tech medical devices.

Novel scaffold-based tissue engineering approaches to healing and regeneration of tendons and ligaments

Acronym: START

Number: STRATEGMED1/233224/10/NCBR/2014


Finance Unit: NCBR (National Centre for Research and Development)

Project manager: dr hab. inż. Wojciech Święszkowski, prof. PW

Function: Project Leader

Term: 2014 – 2018

Project description:

Despite advances in treatment of tendon and ligament injuries, which are the most common musculoskeletal disorders that clinicians address daily, the question of optimal treatment is still unanswered. The main aim of the project is to develop a novel scaffold-based tissue engineering approaches to healing and regeneration of tendons and ligaments (START). We hypothesize that in situ guided personalized tissue engineering, where smart, biodegradable patient/case–specific scaffold is used to provide biomimetic 3D micro- and nano-environments, and delivery required molecules and stem cells, would enhance the tendon/ligament regeneration. The bioactive scaffold will also recruit and stimulate endogenous stem/progenitor cells to assist tissue formation. Additionally, the scaffold, due to its special construction, will allow for continuous in situ modulation of regeneration by providing directly to injury site the stem cells, cytokines, and by applying mechanical stimulation to the tissue throughout whole time of therapy. The modulation will depend on results of in situ biomarkers analyzes. The START will also require the establishment of new non-invasive imaging and analytical techniques for in situ monitoring of regeneration processes. Implementing such multidisciplinary strategies for tissue engineering should greatly enhance the efficacy of treatment of tendon/ligament disorders.

Development of the first Polish complementary molecular navigation system for surgical oncologic treatment

Acronym: MentorEye

Number: STATEGMED1/233624/4/NCBR/2014


Finance Unit: NCBR (National Centre for Research and Development)

Project manager: dr hab. inż. Wojciech Święszkowski, prof. PW

Function: Consortium Member 

Term: 2014 – 2018

Project description:

Aim of this project is creating and preparing for implementation, a novel, computer-molecular method of surgical navigation system for oncologic diseases treatment. Oncologic diseases are second cause of death in Poland and reason of 17% of disabilities. Development of proposed technologies leads to achieving significant progress in overcoming oncologic diseases including both, prophylaxis and treatment. It is based on results of scientific researches on personalization in treatment. The project is concentrated on invention a novel system of surgical navigation supported by molecular mechanisms of neoplastic rAAV vectors, for intraoperative precise marking of the tumour and its radical resection. The role of WUT is the development of physical markers for registration of physical localization of the tumor and navigation in the MentorEye system.

Multifunctional composite nanofibrous biomaterials for peripheral nerve tissue engineering

Acronym: Nano4Nerves

Number: 2013/11/B/ST8/03401

Program: OPUS 6

Finance Unit: NCN (National Science Center)

Project manager: dr hab. inż. Wojciech Święszkowski, prof. PW

Function: Project Leader

Term: 2014 – 2018

Project description:

The main aim of this project is to develop and evaluate novel multifunctional composite nanofibrous
biomaterials (MCNB) mimicking composition and micro- and nanostructure of natural extracellular matrix (ECM) of nerve tissue, and having current-carrying capacity and the capability of localized and controlled release of bio-active agents. The authors hypothesized that such novel biomaterials would enhance ability of neuronal differentiation potential of adipose-derived stem cells (ADSC) in direction of peripheral nerve regeneration both in vitro and in vivo. Two types of the MCNB will be developed and tested: the components blended (BL) and core-shell structured (C/S) composite nanofibrous biomaterials. The both types of MCNB will be fabricated using modified electrospinning methods and will be composed of biodegradable aliphatic polyesters, conductive polymers, natural proteins, and growth factors. The biodegradable polyester such as poly(l-lactic acid-co-ε-caprolactone), P(LLA-CL), will form a matrix of the biomaterials. To achieve a current-carrying capacity, the P(LLA-CL) will be enriched with optimal, non-toxic conductive material selected from the group of two polymers: polyaniline and polypyrrole. To mimic the chemical composition of ECM the biomaterials will also consist of the one of the bio-active natural polymers like collagen, laminin, or fibronectin. To assure the capability of localized and controlled release of bio-active agents the growth factors (GFs) will be encapsulated in the matrix of BL MCNB or in the core of C/S MCNB. The physicochemical, mechanical and electrical properties of the developed biomaterials will be characterized to define the optimal composition and structure of the BL and C/S composites. To evaluate the project hypothesis the both in vitro and in vivo studies using the both types of MNBC will be performed. In vitro biocompatibility and bioactivity of the novel biomaterials in presence of ADSC and electrical potential will be examined. The effects of the method of encapsulation differing kinetics of release of growth factor or the presence of conductive material in nanofibers on the ADSC morphology, growth, and differentiation on novel MCNB will be investigated. The influence of conductivity on GF release will be also evaluated. Additionally, the bio-functionality of the MCNB in the form of 3D tubular structure (scaffold) will be tested in vivo in small animal model – rats. The special method will be elaborated to evaluate behaviour of the novel scaffolds in vivo. A new knowledge on mechanisms of in vivo tissue regeneration in the presence of smart scaffolds and ADSC is expected.

Consolidation of 3D printing, cell biology and material technology for the development of bioprinted meat – a prototype study

Acronym: 3DMuscle

Number: PL-TWIII/5/2016

Program: Polish-Taiwanese contest

Finance Unit: NCBR (National Centre for Research and Development)

Project managers: dr hab. inż. Wojciech Święszkowski, prof. PW and prof. FengHuei Lin

Function: Consortium Member 

Term: 2016 – 2019

Project description:

The prospect of lab-grown meat has intrigued both vegetarians and environmentalists for years. The bioprinted meat would be expected to satisfy a natural human craving for animal protein in a more environmentally-friendly way. Chitosan is a derivative of the naturally occurring carbohydrate chitin and consists of beta 1– 4 linked glucosamine units with varying amounts of N-acetylated units. We have chosen Chitosan, since chitosan dietary supplement purported to decrease body weight and serum lipids through gastrointestinal fat binding. A negatively charged sodium triphosphate (TPP) will be used as a toxic-free ionic crosslinker to interact with polycationic chitosan via ionic gelation. Followed by, the purified soybean protein (SP) will be introduced into the mixture since it may contain about 90% protein on a dry weight basis. There are no known side-effects are associated with the proposed formulation and it appears to be extremely safe. The proposed idea is similar to that of machines that can assemble edible substances like chocolate, sugar and syrup into a paste or any final product with a desired shape. Here, we intend to use the concept of tissue or organ printing often described as bioprinting to produce an in-vitro edible meat.

Development of a Bone Tumor Model with 3D Printed and Lyophilized Scaffolds

Acronym: BonTuMod

Number: 2/POLTUR-1/2016

Program: Polish-Turkish contest

Finance Unit: NCBR (National Centre for Research and Development)

Project manager: dr hab. inż. Wojciech Święszkowski, prof. PW

Function: Project Leader

Term: 2016 – 2018

Project description:

Osteosarcoma is the most common cancerous tumor in a bone. The structure of this tumor is solid, hard and irregular. The tumor tissue is composed of osteocytes, which have lost the normal p53 function. The aim of the project is to use a tissue engineering approach to develop a 3D bone tumor model in vitro and to test its ability to serve as a model in the treatment by using conventional therapeutic approaches such as controlled drug delivery. Two different types of 3D scaffolds will be used to grow osteosarcoma under in vitro conditions. After the fabrication of the 3D PLGA/TCP scaffolds, they will be seeded with Saos2 cells (osteosarcoma) together with HOB (Human osteoblast cells) and HUVEC (Human umbilical vein endothelial cells) to mimic the tumor tissue. Vascularization profile in both models will be obtained by the using of angiogenic factors (e.g. Relaxin). A variety of analytical approaches such as SEM, μCT, mechanical testing, cell viability, histochemistry, and molecular analyses will be performed to assess the effectiveness of the in vitro bone tumor mimic. Responsiveness of the developed models to cytotoxic drugs will be studied as an indicator of proper representation of bone tumor. It is expected that the developed 3D tumor model would help establish a more physiological environment for high throughput drug testing and development. Moreover, it could also be used in personalized medicine by selection the most effective drugs for individual patients using patient’s own cells in the 3D model.


Biomaterials for bone tissue engineering, improvement of biocompatibility and bioactivity by low temperature plasma treatment

NCBiR #PL-TWII/2015, „Polish-Taiwanese/Taiwanese-Polish Joint Research Call”

Hybrid growth factors delivery system supporting bone tissue regeneration

The main objective of the project is to develop a hybrid growth factors delivery system (HSDCW) for tissue engineering and regenerative medicine. The system will mimics the structure and function of the extracellular matrix (ECM) and delivers a controlled growth factors at the implantation site supporting the regeneration of bone tissue. HSDCW be formed from biodegradable polymeric nanofibres, which will contain both the bioceramic nanoparticles and at least two growth factors, for example: bone morphogenic protein – BMP and vascular endothelial growth factor (VEGF). Doses, kinetics of release and sequencing of release will be controlled by the construction of the nanofibers as well as the entire three-dimensional hybrid delivery system.

Duration: 13.12.2011 – 12.12.2015 (Harmonia NCN project # 2011/01/M/ST8/07742)

NanoBRIDGES – Marie Curie IRSES Action

The project is aimed at creating a worldwide network of research partnerships, including various types of research organizations from EU and third countries, with different profiles (computational and empirical risk assessors), focused on the development of new tools for computational risk assessment of engineered nanoparticles (NPs)


“Tissue engineering of osteochondral implants for joint repair”

Project proposal is related to the health area which is one of the targeted research priorities of the Polish-Norwegian Research Programme.


A Systems Approach To Tissue Engineering Processes And Products.
– Fabrication of polymeric scaffold.
– Modifications of the scaffold surface.


International project notfunded (Ministry / NCN) to COST Action MP0701 for 2010-2012.Project Title: Development of methods for producing three-dimensional composites with polymeric matrix modified with nanoparticles.Project manager: dr. Michael J. Wozniak. Grant amount: 1 670 000 PLN.


Knowledge-Based Multicomponent Materials For Durable And Safe Performance:
– Testing and modeling of biomaterials.


Development of a single cell based biosensor for subcellular on-line monitoring of cell performance for diagnosis and healthcare.

– Design device for measure a forces in the cell.


Joined Education for Tissue Engineering: a multidisciplinary approach to regenerate joints
– Development of scaffold.

ExActResoMat (FP6 IP for SME)

External Activation of Resorbable Materials:
– Develop the method for external activation of implant   resorbtion.

COST533 (COST Action FP6)

Biotribology: Materials for improved wear resistance of total artificial joints:
– New materials for articular surfaces in Total Joint Replacement.
– Improvement properties of UHMWPE.
– Wear testing of the total joint replacement.

COST537 (COST Action FP6)

Core laboratories for the improvement of medical devices in clinical practice from the failure of the explanted prostheses analysis (FEPA):
– Analysis of the wear and degradation of biomaterials used in vivo.
– Study of the metallic parts: corrosion, fatigue, fracture.
– Non-distractive methods for retrievals analysis.

BIONANOCORE (Era Net Matera)

Bioactive Nanocomposite Constructs for Regeneration of Articular Cartilage:
– Cartilage Tissue Engineering.

RSHI-DLC-nanocomp (Era Net Matera)

Improvement of resurfacing hip implants with DLC, TiO2 and DLC-p-h nanocomposite coatings

Bilateral grant with Singapore

In vivo bone engineering via combining a novel composite scaffold technology with a growth factor potentiating collagen/heparan sulphate.


Biomaterials for Bone Tissue Engineering, Improvement of Biocompatibility and Bioactivity by Low Temperature Plasma Treatment. Project acronym: Plasma-Bone-BioMater. Polish-Taiwanese/Taiwanese-Polish Joint Research Call NCBR-MOST. 2015 – 2017.


Network on applications of Atomic Force Microscopy to NanoMedicine and Life Sciences COST Action TD1002 (AFM4NanoMed&Bio).



“Biodegradable dental prosthesis, supporting preservation of the alveolar ridge after tooth extraction”

Grant: UMO-2011/01/B/ST8/07559 (OPUS, National Science Center of Poland)

“Three-dimensional composite scaffolds based on degradable polymers and bioceramics incorporated with the growth factors for bone tissue engineering”
Project Manager: Dr inż. Michał J. Woźniak
Funding: 999 800 PLN.

Project Iuventus Plus MNiSW

“Biomateriały kompozytowe polimer-ceramika, o strukturze naśladującej macierz pozakomórkową, dla potrzeb inżynierii tkankowej: procesy degradacji struktury i właściwości mechanicznych” Agreement: 0616/IP2/2011/71. Principal Investigator/Project Manager: Dr inż. Michał J. Woźniak. Funding: 154000 PLN.


Development and preparation of tissue engineering products which will support regeneration and restoration of large bone tissue loss


In Vitro investigation of cartilage-like hydrogel materials and metallic porous structures for improvement of functionality of shoulder joint endoprostheses.


Development of technology for coating the metallic implant with biocompatible polymeric layer playing a role of drug delivery system.

Porous Ti

Made by rapid prototyping method (in collaboration with Wroclaw University of Technology).

Mentor Eye

Opracowanie polskiego komplementarnego systemu molekularnej nawigacji chirurgicznej dla potrzeb leczenia nowotworów.


Zaawansowane techniki badań oddziaływań substancji czynnych z komórkami skóry w celu opracowania innowacyjnej receptury produktu kosmetycznego


Zaawansowane techniki mikro i nano tomografii rentgenowskiej jako nowe narzędzie do badania i oceny produktów inżynierii tkankowej.


Innowacyjna technologia laserowego kształtowania przyrostowego LENS w zastosowaniu do modyfikacji geometrii i biofunkcjonalizacji warstwy powierzchniowej bezcementowych implantów stawu biodrowego